Serpin Pharma, LLC
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| SP16 as a Therapeutic for COVID-19 Induced ARDS (NCT05135624) | Serpin Pharma, LLC | 2021-12-01 |
| SP16 SERPIN-like Peptide Administration in Healthy Individuals (NCT03651089) | Serpin Pharma, LLC | 2018-07-16 |
Track Serpin Pharma, LLC automatically
Every clearance here is in the API, with alerts when new ones post.